-
公开(公告)号:US20100197644A1
公开(公告)日:2010-08-05
申请号:US12643504
申请日:2009-12-21
申请人: Markus Berger , Jan Dahmén , Karl Edman , Anders Eriksson , Balint Gabos , Thomas Hansson , Martin Hemmerling , Krister Henriksson , Svetlana Ivanova , Matti Lepistö , Darren McKerrecher , Magnus Munck af Rosenschöld , Stinabritt Nilsson , Hartmut Rehwinkel , Camilla Taflin
发明人: Markus Berger , Jan Dahmén , Karl Edman , Anders Eriksson , Balint Gabos , Thomas Hansson , Martin Hemmerling , Krister Henriksson , Svetlana Ivanova , Matti Lepistö , Darren McKerrecher , Magnus Munck af Rosenschöld , Stinabritt Nilsson , Hartmut Rehwinkel , Camilla Taflin
IPC分类号: A61K31/56 , A61K31/5377 , A61K31/501 , A61K31/506 , A61K31/4709 , A61K31/4439 , A61K31/4245 , A61K31/427 , A61K31/428 , A61K31/422 , A61K31/4196 , A61K31/4184 , A61K31/4178 , A61K31/416 , C07D413/10 , C07D403/04 , C07D403/12 , C07D215/12 , C07D401/12 , C07D271/02 , C07D417/12 , C07D277/587 , C07D263/38 , C07D263/40 , C07D249/12 , C07D235/26 , C07D233/90 , C07D231/56 , A61P29/00 , A61P11/06
CPC分类号: C07D231/56 , C07D401/04 , C07D401/12 , C07D403/04 , C07D403/12 , C07D405/12 , C07D405/14 , C07D409/12 , C07D409/14 , C07D413/12 , C07D417/12 , C07D417/14 , C07D471/04
摘要: Compounds of formula (I): The present invention relates to novel indazolyl ester or amide derivatives, to pharmaceutical compositions comprising such derivatives, to processes for preparing such novel derivatives and to the use of such derivatives as medicaments
摘要翻译: 式(I)化合物:本发明涉及新的吲唑基酯或酰胺衍生物,包含这些衍生物的药物组合物,制备这种新衍生物的方法以及使用这些衍生物作为药物
-
公开(公告)号:US20110071194A1
公开(公告)日:2011-03-24
申请号:US12959027
申请日:2010-12-02
申请人: Markus Berger , Jan Dahmén , Karl Edman , Anders Eriksson , Balint Gabos , Thomas Hansson , Martin Hemmerling , Krister Henriksson , Svetlana Ivanova , Matti Lepistö , Darren McKerrecher , Magnus Munck af Rosenschöld , Stinabritt Nilsson , Hartmut Rehwinkel , Camilla Taflin
发明人: Markus Berger , Jan Dahmén , Karl Edman , Anders Eriksson , Balint Gabos , Thomas Hansson , Martin Hemmerling , Krister Henriksson , Svetlana Ivanova , Matti Lepistö , Darren McKerrecher , Magnus Munck af Rosenschöld , Stinabritt Nilsson , Hartmut Rehwinkel , Camilla Taflin
IPC分类号: A61K31/4439 , C07D401/12 , A61P29/00 , A61P11/06
CPC分类号: C07D231/56 , C07D401/04 , C07D401/12 , C07D403/04 , C07D403/12 , C07D405/12 , C07D405/14 , C07D409/12 , C07D409/14 , C07D413/12 , C07D417/12 , C07D417/14 , C07D471/04
摘要: Compounds of formula (I): The present invention relates to novel indazolyl ester or amide derivatives, to pharmaceutical compositions comprising such derivatives, to processes for preparing such novel derivatives and to the use of such derivatives as medicaments
摘要翻译: 式(I)化合物:本发明涉及新的吲唑基酯或酰胺衍生物,包含这些衍生物的药物组合物,制备这种新型衍生物的方法以及使用这些衍生物作为药物
-
公开(公告)号:US07728030B2
公开(公告)日:2010-06-01
申请号:US12005066
申请日:2007-12-20
申请人: Markus Berger , Jan Dahmén , Karl Edman , Anders Eriksson , Balint Gabos , Thomas Hansson , Martin Hemmerling , Krister Henriksson , Svetlana Ivanova , Matti Lepistö , Darren McKerrecher , Magnus Munck af Rosenschöld , Stinabritt Nilsson , Hartmut Rehwinkel , Camilla Taflin
发明人: Markus Berger , Jan Dahmén , Karl Edman , Anders Eriksson , Balint Gabos , Thomas Hansson , Martin Hemmerling , Krister Henriksson , Svetlana Ivanova , Matti Lepistö , Darren McKerrecher , Magnus Munck af Rosenschöld , Stinabritt Nilsson , Hartmut Rehwinkel , Camilla Taflin
IPC分类号: A61K31/415 , C07D231/56 , C07D487/00 , C07D231/00
CPC分类号: C07D231/56 , C07D401/04 , C07D401/12 , C07D403/04 , C07D403/12 , C07D405/12 , C07D405/14 , C07D409/12 , C07D409/14 , C07D413/12 , C07D417/12 , C07D417/14 , C07D471/04
摘要: Compounds of formula (I): The present invention relates to novel indazolyl ester or amide derivatives, to pharmaceutical compositions comprising such derivatives, to processes for preparing such novel derivatives and to the use of such derivatives as medicaments.
摘要翻译: 式(I)化合物:本发明涉及新的吲唑基酯或酰胺衍生物,包含这些衍生物的药物组合物,制备这种新型衍生物的方法以及使用这些衍生物作为药物。
-
公开(公告)号:US08143290B2
公开(公告)日:2012-03-27
申请号:US12959027
申请日:2010-12-02
申请人: Markus Berger , Jan Dahmén , Karl Edman , Anders Eriksson , Balint Gabos , Thomas Hansson , Martin Hemmerling , Krister Henriksson , Svetlana Ivanova , Matti Lepistö , Darren McKerrecher , Magnus Munck af Rosenschöld , Stinabritt Nilsson , Hartmut Rehwinkel , Camilla Taflin
发明人: Markus Berger , Jan Dahmén , Karl Edman , Anders Eriksson , Balint Gabos , Thomas Hansson , Martin Hemmerling , Krister Henriksson , Svetlana Ivanova , Matti Lepistö , Darren McKerrecher , Magnus Munck af Rosenschöld , Stinabritt Nilsson , Hartmut Rehwinkel , Camilla Taflin
IPC分类号: A61K31/4427 , C07D401/02
CPC分类号: C07D231/56 , C07D401/04 , C07D401/12 , C07D403/04 , C07D403/12 , C07D405/12 , C07D405/14 , C07D409/12 , C07D409/14 , C07D413/12 , C07D417/12 , C07D417/14 , C07D471/04
摘要: Compounds of formula (I): The present invention relates to novel indazolyl ester or amide derivatives, to pharmaceutical compositions comprising such derivatives, to processes for preparing such novel derivatives and to the use of such derivatives as medicaments.
摘要翻译: 式(I)化合物:本发明涉及新的吲唑基酯或酰胺衍生物,包含这些衍生物的药物组合物,制备这种新型衍生物的方法以及使用这些衍生物作为药物。
-
公开(公告)号:US20120252770A1
公开(公告)日:2012-10-04
申请号:US13429177
申请日:2012-03-23
申请人: Markus Berger , Jan Dahmén , Karl Edman , Anders Eriksson , Balint Gabos , Thomas Hansson , Martin Hemmerling , Krister Henriksson , Svetlana Ivanova , Matti Lepistö , Darren McKerrencher , Magnus Munck af Rosenschöld , Stinabritt Nilsson , Hartmut Rehwinkel , Camilla Taflin
发明人: Markus Berger , Jan Dahmén , Karl Edman , Anders Eriksson , Balint Gabos , Thomas Hansson , Martin Hemmerling , Krister Henriksson , Svetlana Ivanova , Matti Lepistö , Darren McKerrencher , Magnus Munck af Rosenschöld , Stinabritt Nilsson , Hartmut Rehwinkel , Camilla Taflin
IPC分类号: A61K31/416 , A61K31/5377 , A61K31/501 , A61K31/506 , A61K31/437 , A61K31/4439 , A61K31/4245 , A61K31/427 , A61K31/428 , A61K31/422 , A61K31/4196 , A61K31/4184 , C07D413/10 , C07D401/04 , C07D471/04 , C07D401/12 , C07D417/12 , C07D413/12 , A61K31/4192 , C07D231/56 , A61P29/00 , A61P11/06 , A61P11/00 , C07D405/12 , C07D403/12 , C07D409/12 , C07D417/14 , A61K31/56
CPC分类号: C07D231/56 , C07D401/04 , C07D401/12 , C07D403/04 , C07D403/12 , C07D405/12 , C07D405/14 , C07D409/12 , C07D409/14 , C07D413/12 , C07D417/12 , C07D417/14 , C07D471/04
摘要: Compounds of formula (I): The present invention relates to novel indazolyl ester or amide derivatives, to pharmaceutical compositions comprising such derivatives, to processes for preparing such novel derivatives and to the use of such derivatives as medicaments
摘要翻译: 式(I)化合物:本发明涉及新的吲唑基酯或酰胺衍生物,包含这些衍生物的药物组合物,制备这种新型衍生物的方法以及使用这些衍生物作为药物
-
公开(公告)号:US20120065173A1
公开(公告)日:2012-03-15
申请号:US13224382
申请日:2011-09-02
申请人: Markus Berger , Lena Bergström , Jan Dahmén , Anders Eriksson , Balint Gabos , Martin Hemmerling , Krister Henriksson , Svetlana Ivanova , Matti Lepistö , Stinabritt Nilsson , Camilla Taflin , Darren McKerrecher , Hartmut Rehwinkel
发明人: Markus Berger , Lena Bergström , Jan Dahmén , Anders Eriksson , Balint Gabos , Martin Hemmerling , Krister Henriksson , Svetlana Ivanova , Matti Lepistö , Stinabritt Nilsson , Camilla Taflin , Darren McKerrecher , Hartmut Rehwinkel
IPC分类号: A61K31/416 , C07D401/04 , A61K31/4439 , C07D401/12 , A61K31/4709 , C07D405/12 , C07D401/14 , A61K31/444 , C07D403/12 , A61K31/4178 , C07D413/12 , A61K31/422 , A61K31/56 , A61P11/06 , A61P29/00 , A61P35/00 , A61P37/08 , A61P37/06 , A61P11/00 , A61P17/00 , A61P17/06 , A61P17/04 , A61P1/16 , A61P1/00 , A61P27/02 , C07D231/56
CPC分类号: C07D231/56
摘要: Compounds of formula (I): or a pharmaceutically acceptable salt thereof; compositions comprising them, processes for preparing them and their use in medical therapy (for example modulating the glucocorticoid receptor in a warm blooded animal).
摘要翻译: 式(I)化合物或其药学上可接受的盐; 包含它们的组合物,其制备方法及其在药物治疗中的用途(例如调节温血动物中的糖皮质激素受体)。
-
公开(公告)号:US20080214641A1
公开(公告)日:2008-09-04
申请号:US12005066
申请日:2007-12-20
申请人: Markus Berger , Jan Dahmen , Karl Edman , Anders Eriksson , Balint Gabos , Thomas Hansson , Martin Hemmerling , Krister Henriksson , Svetlana Ivanova , Matti Lepisto , Darren McKerrecher , Magnus Munck af Rosenschold , Stinabritt Nilsson , Hartmut Rehwinkel , Camilla Taflin
发明人: Markus Berger , Jan Dahmen , Karl Edman , Anders Eriksson , Balint Gabos , Thomas Hansson , Martin Hemmerling , Krister Henriksson , Svetlana Ivanova , Matti Lepisto , Darren McKerrecher , Magnus Munck af Rosenschold , Stinabritt Nilsson , Hartmut Rehwinkel , Camilla Taflin
IPC分类号: A61K31/416 , C07D231/56 , A61P29/00
CPC分类号: C07D231/56 , C07D401/04 , C07D401/12 , C07D403/04 , C07D403/12 , C07D405/12 , C07D405/14 , C07D409/12 , C07D409/14 , C07D413/12 , C07D417/12 , C07D417/14 , C07D471/04
摘要: Compounds of formula (I): The present invention relates to novel indazolyl ester or amide derivatives, to pharmaceutical compositions comprising such derivatives, to processes for preparing such novel derivatives and to the use of such derivatives as medicaments
摘要翻译: 式(I)化合物:本发明涉及新的吲唑基酯或酰胺衍生物,包含这些衍生物的药物组合物,制备这种新衍生物的方法以及使用这些衍生物作为药物
-
8.Indazolyl sulphonamide derivatives useful as glucocorticoid modulators 失效
标题翻译: 用作糖皮质激素调节剂的吲唑基磺酰胺衍生物公开(公告)号:US08030340B2
公开(公告)日:2011-10-04
申请号:US11986555
申请日:2007-11-21
申请人: Markus Berger , Lena Bergstrom , Jan Dahmen , Anders Eriksson , Balint Gabos , Martin Hemmerling , Krister Henriksson , Svetlana Ivanova , Matti Lepisto , Stinabritt Nilsson , Camilla Taflin , Hartmut Rehwinkel , Darren McKerrecher
发明人: Markus Berger , Lena Bergstrom , Jan Dahmen , Anders Eriksson , Balint Gabos , Martin Hemmerling , Krister Henriksson , Svetlana Ivanova , Matti Lepisto , Stinabritt Nilsson , Camilla Taflin , Hartmut Rehwinkel , Darren McKerrecher
IPC分类号: A01N43/56
CPC分类号: C07D231/56 , C07D401/04 , C07D401/12 , C07D401/14 , C07D403/12 , C07D405/12 , C07D413/12
摘要: Compounds of formula (I): or a pharmaceutically acceptable salt thereof, compositions comprising them, processes for preparing them and their use in medical therapy (for example modulating the glucocorticoid receptor in a warm blooded animal).
摘要翻译: 式(I)化合物或其药学上可接受的盐; 包含它们的组合物,其制备方法及其在药物治疗中的用途(例如调节温血动物中的糖皮质激素受体)。
-
公开(公告)号:US20080207721A1
公开(公告)日:2008-08-28
申请号:US11986555
申请日:2007-11-21
申请人: Markus Berger , Lena Bergstrom , Jan Dahmen , Anders Eriksson , Balint Gabos , Martin Hemmerling , Krister Henriksson , Svetlana Ivanova , Matti Lepisto , Stinabritt Nilsson , Camilla Taflin , Darren McKerrecher , Hartmut Rehwinkel
发明人: Markus Berger , Lena Bergstrom , Jan Dahmen , Anders Eriksson , Balint Gabos , Martin Hemmerling , Krister Henriksson , Svetlana Ivanova , Matti Lepisto , Stinabritt Nilsson , Camilla Taflin , Darren McKerrecher , Hartmut Rehwinkel
IPC分类号: A61K31/416 , C07D231/56
CPC分类号: C07D231/56 , C07D401/04 , C07D401/12 , C07D401/14 , C07D403/12 , C07D405/12 , C07D413/12
摘要: Compounds of formula (I): or a pharmaceutically acceptable salt thereof, compositions comprising them, processes for preparing them and their use in medical therapy (for example modulating the glucocorticoid receptor in a warm blooded animal).
摘要翻译: 式(I)化合物或其药学上可接受的盐,包含它们的组合物,其制备方法及其在药物治疗中的用途(例如调节温血动物中的糖皮质激素受体)。
-
公开(公告)号:US08916600B2
公开(公告)日:2014-12-23
申请号:US13490204
申请日:2012-06-06
申请人: Markus Berger , Hartmut Rehwinkel , Jan Dahmén , Anders Eriksson , Thomas Hansson , Nafizal Hossain , Per Tomas Klingstedt , Matti Lepistö , Stinabritt Nilsson , Martin Hemmerling , Karl Edman
发明人: Markus Berger , Hartmut Rehwinkel , Jan Dahmén , Anders Eriksson , Thomas Hansson , Nafizal Hossain , Per Tomas Klingstedt , Matti Lepistö , Stinabritt Nilsson , Martin Hemmerling , Karl Edman
IPC分类号: A61K31/416 , C07D231/54 , C07D405/14 , C07D409/12 , C07D231/56 , C07D409/14 , C07D403/12 , C07D401/12 , C07D405/12 , C07D401/14 , C07D403/10 , C07D413/12
CPC分类号: C07D409/14 , A61K31/416 , A61K31/4439 , A61K45/06 , C07D231/56 , C07D401/12 , C07D401/14 , C07D403/10 , C07D403/12 , C07D405/10 , C07D405/12 , C07D405/14 , C07D407/14 , C07D409/12 , C07D413/12
摘要: A compound of formula Ia: The present invention relates to novel indazolyl derivatives, to pharmaceutical compositions comprising such derivatives, to processes for preparing such novel derivatives and to the use of such derivatives as medicaments.
摘要翻译: 式Ia化合物:本发明涉及新的吲唑基衍生物,包含该衍生物的药物组合物,制备这种新型衍生物的方法以及使用这些衍生物作为药物。
-
-
-
-
-
-
-
-
-